Elba Perez
General Practice · Trujillo Alto, PRNPI 1124027859
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (54.3%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 5 manufacturers reported payments, led by Merck at 30.3% of the total. Reporting peaked in 2019 at $4,189 and has fallen 98.7% since, to $53 in 2021. Among general practice clinicians in PR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 30 payments — averaging $179.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$2K
- Novo Nordisk AS$1K
- E.r. Squibb & Sons, L.L.C.$1K
- Eli Lilly$1K
- Novo Nordisk$65
Across 502 payments — averaging $1776.83 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Merck$384K
- Sanofi Pasteur Inc.$159K
- Novo Nordisk AS$150K
- Eli Lilly Export S.A. Puerto Rico Branch$132K
- Pfizer$48K
- Eli Lilly$19K
What the payments were for
- Consulting fees$1,14421%
- Travel & lodging$2,92554%
- Food & beverage$1,25223%
- Education$651%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 17 | $1,634 |
| Novo Nordisk AS | 6 | $1,481 |
| E.r. Squibb & Sons, L.L.C. | 1 | $1,144 |
| Eli Lilly | 4 | $1,063 |
| Novo Nordisk | 2 | $65 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- V114$1,237
How this compares
$5,386 in reported general payments places this provider in the 95th percentile of 3,586 general practice providers in Puerto Rico.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Insulin Glargine-Yfgn | 83 | $7,666 |
| Pioglitazone-MetforminPioglitazone Hcl/Metformin Hcl | 12 | $1,397 |
| Levothyroxine Sodium | 65 | $1,352 |
| Atorvastatin Calcium | 99 | $1,344 |
| Losartan Potassium | 80 | $1,132 |
| Rosuvastatin Calcium | 61 | $988 |
| Irbesartan | 20 | $896 |
| Gabapentin | 42 | $816 |
| Metformin Hcl | 79 | $792 |
| Irbesartan-HydrochlorothiazideIrbesartan/Hydrochlorothiazide | 13 | $642 |
| Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide | 21 | $637 |
| Metoprolol Succinate | 17 | $630 |
| Levo-TLevothyroxine Sodium | 14 | $424 |
| Simvastatin | 28 | $402 |
| Alendronate Sodium | 39 | $364 |
Paid to pharmacies, not to this prescriber.
Other general practice in Trujillo Alto
- Eileen Diaz CabreraTrujillo Alto$5K
- Wilfredo CuevasSan Lorenzo$530K
- Julio BacoMayaguez$268K
- Soria Diaz BaezPonce$192K
- Carlos RomanCanovanas$140K
- William E TorresSan Juan$86K
- Rafael Mendoza RodriguezPonce$77K
- Frank Perez NogueiraSan German$70K
- Vivian Tamayo AgraitSan Juan$64K
- William Soto AvilesToa Baja$63K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.